Abstract
Introduction
An emerging concept in gene expression regulation is that the fate and function of mRNAs is controlled by dynamic, and in some cases, reversible nucleotide modifications. The initial concept of the epitranscriptome came with the transcriptome-wide mapping of thousands of internally located modified nucleotide N 6 -methyladenosine (m 6 A) residues in the transcriptome 1, 2 . m 6 A mapping revealed diverse patterns of methylation in thousands of transcripts in various cells and tissues 1, 2 .
A major goal in the field of epitranscriptomics has been to establish whether other modified nucleotides are also highly prevalent in mRNA. Two studies in 2016 identified N 1 -methyladenosine (m 1 A) as an abundant modification 3, 4 . In these studies, m 1 A was mapped by sequencing mRNA fragments immunoprecipitated with a commercial m 1 A antibody from MBL.
Hundreds of m 1 A sites were identified in hundreds of mRNAs. One study estimated the average stoichiometry of m 1 A at 20% 3 . Furthermore, most m 1 A sites were located near start codons, which was suggested to enhance translation 3 . Hence, these studies identified m 1 A as an abundant and functional modification affecting hundreds of mRNAs.
Two subsequent studies proposed different maps of m 1 A. One study argued that m 1 A was exceptionally rare in mRNA 5 . In this study, the antibody-bound RNA was reverse transcribed with a reverse transcriptase that efficiently introduces misincorporations at m 1 A. Using this method, the authors found that m 1 A was rarely present in the RNA immunoprecipitated with the m 1 A antibodies 5 . Although mRNA fragments from 5' UTRs and start codon-proximal regions were immunoprecipitated, these fragments did not generate misincorporations. Thus, the authors proposed that mRNA fragments from the 5' UTR may be nonspecifically enriched during immunoprecipitation 5 . Only two mRNAs contained high confidence m 1 A sites: C9orf100 and MT-ND5, a cytosolic and a mitochondrial mRNA, respectively 5 . Twelve other mRNAs were also detected at very low stoichiometry.
The second study mapped m 1 A to 740 sites, 473 of which were in mRNA and lncRNA. In the mRNAs, the majority of sites were found in the 5' UTR; twenty-two of which the authors localized to the first nucleotide of the transcript. Based on their location, the authors proposed that m 1 A forms a novel type of cap structure in which m 1 A immediately follows the 7-methylguanosine (m 7 G) cap of mRNA (m 7 G-ppp-m 1 A). A re-analysis of this data has argued that the few start codon-proximal m 1 A sites mapped in this study were not mapped to the genome properly, and in fact represent transcription start sites 6 .
In summary, very divergent m 1 A maps have been generated. The major question is whether m 1 A sites are indeed at transcription start sites or start codons, or neither, and why these sites are so prominent in m 1 A-mapping studies. Additionally, it is not clear if m 1 A sites are indeed high stoichiometry modifications as reported in the initial study 3 , or low-stoichiometry and rare as reported in another study 5 .
To resolve the question of the prevalence and location of m 1 A in the transcriptome, we used both a high-resolution m 1 A-mapping method as well as a bioinformatic approach, termed misincorporation mapping, to localize m 1 A in the transcriptome. Misincorporation mapping takes advantage of the ability of m 1 A and certain other modified nucleotides to induce misincorporations during the reverse transcription step in RNA-Seq. By using ultra-deep RNA-Seq datasets, we discovered that very few transcriptomic sites generate misincorporations in multiple independent RNA-Seq datasets. Only the MT-ND5 mitochondrial transcript and the MALAT1 noncoding RNA generated statistically significant misincorporations, demonstrating the rarity of high stoichiometry m 1 A sites. To understand why misincorporation mapping reveals few m 1 A sites while m 1 A
antibodies detect large number of sites, we mapped m 1 A at high resolution using the same MBL antibody used in all previous studies. Our mapping recapitulated the selective binding of the MBL m 1 A antibody to transcription start nucleotides in mRNA. However, we found that the m 1 A
antibody also directly binds the m 7 G cap structure, and this m 1 A-independent binding property expected, the misincorporations were predominantly A!T transitions, which are characteristic of m 1 A 7, 8 . These site-specific misincorporations were detected in all 20 replicates, confirming that the A!T transitions were not stochastic sequencing errors.
Misincorporation mapping can also detect other hard stop modifications. These included 1-methyl-3-(3-amino-3-carboxypropyl)pseudouridine and m 3 U (Extended Data Fig. 2b ). On the other hand, modifications that do not significantly affect reverse transcription fidelity, such as m 6 A, pseudouridine, N 4 -acetylcytidine, 2'-O-methylated nucleotides, and m 7 G, did not induce misincorporations (Extended Data Fig. 2c ). These data demonstrate that hard stop modifications could be reliably detected in this dataset.
We considered the possibility that m 1 A detection could be impaired in this approach, since m 1 A can convert to m 6 A through the Dimroth rearrangement, a heat and base-catalyzed reaction 11 (Extended Data Fig. 2d ). To estimate m 1 A loss during the preparation of the ultra-deep sequencing libraries, we examined the m 1 A at position 1,322 in the 28S rRNA. This site is reported to be methylated at near complete stoichiometry 12 . and m 1 A residues should be detectable throughout the transcriptome using this dataset.
m 1 A-induced misincorporations are not readily detected in mRNA
Next, we wanted to map m 1 A at single-nucleotide resolution in mRNA. Although the number of reads is exceptionally high in this ultra-deep RNA-seq dataset, we reasoned that the read depth may not be sufficient on individual transcripts to detect m 1 A in low abundance mRNAs or mRNAs with low stoichiometry m 1 A. In order to detect m 1 A, an m 1 A residue needs to have been reverse transcribed a sufficient number of times during library preparation to detect misincorporations. Since m 1 A sites were reported to have on average a 20% stoichiometry 3 , we thus set a threshold number of 500 unique reads on any given nucleotide to detect m 1 A sites. At this stoichiometry, 100 reverse transcription events would encounter m 1 A. Of these 100 reverse transcription events, approximately 20% would read through, and most of these would be associated with a misincorporation 7, 8 . At this read depth, misincorporations should be readily detected in multiple replicates. Thus, to detect m 1 A in mRNA, we restricted our search to approximately 8 million adenosine residues in the transcriptome that showed a read depth of >500 reads (Extended Data  Fig. 3a) .
Analysis of the 3 billion reads provided by this dataset showed 14 high-confidence nucleotide positions across the transcriptome that showed misincorporations in more than one replicate (see Methods). Of these, 12 occurred at adenosine residues (Extended Data Tables 1,2 ). Most of these modified adenosines were found in mitochondrial tRNAs and could be identified as m 1 A since they occurred at known m 1 A positions in mitochondrial tRNAs 13 (Extended Data Table 2 ).
We also detected a modified adenosine in mascRNA (MALAT1-associated small cytoplasmic RNA), a short tRNA-like ncRNA that is derived from endonucleolytic processing of MALAT1 14 (Fig.   1c) . Notably, this modified adenosine is found at a position corresponding to position 58 in the Tloop of tRNAs (Fig. 1d) Besides these noncoding RNAs, the previously reported m 1 A-containing MT-ND5 mitochondrial mRNA contained a modified adenosine (Extended Data Table 2 ). At this modified adenosine, a misincorporation rate of 13.5% was present, in agreement with a recent finding of m 1 A-induced misincorporations at this position in this transcript 5 . This mRNA was also the only mRNA previously found to have relatively high m 1 A stoichiometry (exceeding 50% in a number of cell types and tissues) in a recent reanalysis of m 1 A in the transcriptome 5 . The high degree of misincorporations compared to background levels supports the high sensitivity of this method.
We next examined misincorporations at other mitochondrial mRNAs with annotated m 1 A sites.
Studies by Safra et al. 5 and Li et al. 16 identified 11 and 5 putative mitochondrial m 1 A-containing protein-coding genes, respectively. Four mitochondrial mRNAs were common to both studies (MT-ND5, MT-CO1, MT-CO2 and MT-CO3). Except for MT-ND5, the misincorporation rates for these mRNAs were found to be very low when examining purified poly(A) RNA (less than 0.7% and 2.1% in the Safra and Li studies, respectively). However, when these authors enriched m 1 Acontaining mRNA using the m 1 A antibody, misincorporations could be detected, suggesting that rare m 1 A-containing transcripts are found in cells. We therefore further examined these sites in our study leveraging the exceptional read depth across the mitochondria (average ~1 million reads/nucleotide). Similarly, we found that with the exception of MT-ND5 which had a misincorporation rate of 13.5%, the misincorporation rates for all other putative m 1 A sites was less than 0.4% (Extended Data Fig. 3b , Extended Data Table 3 ). Taken together, these earlier studies and our data demonstrate that MT-ND5 is unique in containing readily detectable m 1 A, and other mitochondrial mRNAs may contain m 1 A, but only at very low stoichiometries.
We also detected three additional sites of modifications in cytosolic mRNAs, with only one site being a modified adenosine (Extended Data Table 2 ). Notably, when we examined cytosolic mRNAs that were previously reported by earlier mapping studies 3 to have the highest stoichiometry of m 1 A (i.e. >50%) such as CCDC71, DLST, and STK16 lacked evidence of A!T transitions based on our misincorporation mapping (Extended Data Fig. 3c , Extended Data Table 1 ).
We did not detect any high-confidence misincorporations at cytidine residues in mRNA (Extended Data Table 2 ), in contrast to a recent study that detected m 3 C, a hard-stop nucleotide, in mammalian mRNA by mass spectrometry 17 .
Although misincorporation mapping demonstrated that few mRNAs have m 1 A or other hard stop modifications, we could not conclusively rule out modifications at the very 5' end of RNAs. This is because RNA-seq typically does not provide coverage at the extreme 5' ends of RNAs and so detecting misincorporations in this region is not possible (see Extended Data Fig. 1a ) 18 .
Overall, the paucity of m 1 A sites in mRNA using misincorporation mapping supports the idea that m 1 A is not a highly prevalent and high stoichiometry modification, and is instead exceptionally rare in mRNA. In m 1 A miCLIP, we crosslink the m 1 A-specific antibody to sheared RNA (Fig. 2a) . UV crosslinking was previously shown to reduce nonspecific RNA binding and increase peak resolution in mapping studies 19 . RNA fragments crosslinked to the antibody were then purified and cloned as a cDNA library. Terminations introduced during reverse transcription were then analyzed to determine the positions of m 1 A throughout the transcriptome.
The library generated in m 1 A miCLIP is different from the initial m 1 A mapping methods 3,4 since those libraries are generated in way that the cDNA ends are not preserved and produce peaks that are displaced 3' from the actual location of the m 1 A (see Extended Data Fig. 1a) . We chose to preserve the cDNA ends since they can identify the exact sites of m 1 A-induced terminations. (Fig. 2c) .
More precisely, the clusters were located at mRNA transcription start sites (Fig. 2d) . antibody is expected to cause reverse transcription terminations within several nucleotides of the site of the antibody-RNA adduct 19 . As expected, we found that in miCLIP, terminations were enriched not only at the transcription start site, but also prominently at the +1 position relative to the transcription start site (Fig. 2e) , with additional terminations sometimes seen between position +2 and +3 (Fig. 2e) . Thus, the MBL m 1 A antibody binds at or near mRNA transcription start nucleotides.
We considered the possibility that terminations near the transcription start nucleotide could simply reflect general behavior of the reverse transcriptase as it approaches the 5' end of the mRNA. To test this, we examined the input RNA fragments in the RNA-seq dataset prepared using the same library cloning strategy as m 1 A miCLIP. In general, RNA-seq reads terminated almost exclusively at the transcription start nucleotide, while m 1 A miCLIP reads often terminated at position +1, and up to +3, and in cases of some transcripts, up to +5 (Fig. 2e, Extended Data Fig. 5c ). i.e., m 7 G-ppp-m 1 A (m) . We therefore treated cellular RNA with P1 nuclease, which digests all internal nucleotides to mononucleotides, but leaves the cap dinucleotide intact (see Methods).
We readily detected cap dinucleotides using high-resolution liquid chromatography and mass spectrometry using positive ion mode detection. To achieve this, we developed a multiple reaction monitoring protocol based on the fragment ion transitions from distinct dinucleotide precursor species (see Methods). (Fig. 3a) .
We next examined cap dinucleotides prepared by digesting poly(A) RNA from HEK293T cells. We readily detected m Since our mass spectrometry analysis does not support the idea that m 1 A was present at the transcription start nucleotide, we wanted to directly and sensitively determine the identity of the transcription start nucleotide that is recovered by the m 1 A antibody. We therefore used twodimensional thin-layer chromatography (2D-TLC), which can be used to identify and quantify the first encoded nucleotide 28 . In this approach, mRNA is decapped, and the exposed 5' end of the mRNA is radiolabeled, permitting sensitive detection of the first transcribed nucleotide. The radiolabeled nucleotide species are then resolved using 2D-TLC 28 . Based in the mobility of each species, the identity of the transcription start nucleotide can be determined.
We subjected poly ( 4a ). However, a commercially available cap analog, m 7 G-ppp-A, was a relatively effective competitor, with an IC 50 of 480 nM compared to 100 nM for m 1 A (Fig. 4b) . Thus, the MBL m 1 A antibody can bind the adenine-containing extended cap structure.
We next further characterized the cap-binding properties of the MBL m 1 A antibody. Based on our miCLIP analysis, transcription start site-associated m 1 A read clusters were preferentially enriched on mRNAs that initiated with adenosine (see Fig. 2g ). Hence, we asked whether the antibody had a preference for adenosine after the m 7 G compared to other nucleotides. To test this, we To test this idea, we wanted to examine m 1 A peaks using an antibody that does not show crossreactivity with the mRNA cap. We therefore tested an additional m 1 A antibody from Abcam that recently became commercially available. Unlike the MBL m 1 A antibody, the Abcam m 1 A antibody was specific for m 1 A but did not show competition with the m 7 G-ppp-A cap analog (Fig. 4d) .
Therefore, the Abcam antibody does not bind the mRNA cap.
We first confirmed that m 1 A miCLIP using HEK293T poly(A) RNA and either the Abcam or MBL antibody detects m 1 A. Indeed, in both cases, we observed a robust peak at the m 1 A sites in MT-ND5 and MT-RNR2, the mitochondrially encoded 16S RNA (Fig. 4e) , confirming the ability of each antibody to detect validated m 1 A sites in mRNA.
We next asked if m 1 A miCLIP performed using the m 1 A-specific Abcam antibody showed the same transcriptome-wide enrichment of m 1 A-containing fragments in the 5' UTR as seen with the MBL m 1 A antibody 3, 4 . As expected, the metagene of the miCLIP fragments using the MBL antibody showed a prominent 5' UTR enrichment (Fig. 4f) Fig.   6a ). However, the location of reads was different (Extended Data Fig. 6b ). In particular, the 5' ends of the miCLIP reads approached the transcription start site, while reads from Dominissini et al. were located downstream of the transcription start site (Extended Data Fig. 6b, insets) . This lateral displacement of peaks towards the start codon is consistent with the library cloning method used in this earlier method (see Extended Data Fig. 1a ).
In earlier m 1 A mapping studies, accumulations of reads, or in some cases, "troughs" of reduced read coverage due to a putative m 1 A site, were used to predict m 1 A residues to start codons in mRNA 3 . Unlike peaks and troughs, which are a common nonspecific variation in RNA-seq data, miCLIP provides more precise positioning by detecting exact sites of antibody-induced crosslinks (see Fig. 2b , e and Extended Data Fig. 5c, 6b ).
We additionally re-examined the Li et al. Fig. 1a) . Thus, the start codon-proximal m 1 A sites mapped in previous studies likely reflect displaced peaks that derive from antibody binding to transcription start nucleotides. Cui, P., Lin, Q., Ding, F., Xin, C., Gong, W., Zhang, L., Geng, J., Zhang, B., Yu, X. Carninci, P., Sandelin, A., Lenhard, B., Katayama, S., Shimokawa, K., Ponjavic, J., Semple, C.A., Taylor, M.S., Engstrom, P.G., Frith, M.C., Forrest, A.R., Alkema, W.B., Tan, S.L., Plessy, C., Kodzius, R., Ravasi, T., Kasukawa, T., Fukuda, S., KanamoriKatayama, M., Kitazume, Y., Kawaji, H., Kai, C., Nakamura, M., Konno, H., Nakano, K., Mottagui-Tabar, S., Arner, P., Chesi, A., Gustincich, S., Persichetti, F., Suzuki, H., Grimmond, S.M., Wells, C.A., Orlando, V., Wahlestedt, C., Liu, E.T., Harbers, M., Kawai, J., Bajic, V. 
Code availability
Custom scripts and computational code used in this study are available upon request.
Alignment of reads for misincorporation mapping
Raw reads from the ultra-deep RNA-seq dataset used for this study 10 were downloaded from GEO (accession code: GSE33029). This RNA-seq dataset was prepared using standard reverse transcription with SuperScript III, an enzyme expected to produce misincorporations at m 1 A positions 8 . Variants identified in the genomic DNA corresponding to this dataset were acquired from http://snyderome.stanford.edu. Coordinates of other SNPs that may be present in the DNA sequence were downloaded from the SNP database dbSNP (February 2017 build; https://www.ncbi.nlm.nih.gov/projects/SNP/). Read alignment of forward and reverse read mates was performed using STAR (version 2.5.3a) and the hg19 genome build. Alignment incorporated removal of PCR duplicates, and clipping of 10 bases on either end of each read, since the ends of Illumina reads are prone to sequencing error 34 . Only reads that mapped to a single location in the genome were used for downstream analysis. A maximum of one mismatch per read was permitted for alignment.
Misincorporation mapping
To identify misincorporations, aligned reads were analyzed using Rsamtools Pileup (version 1.27.16). This program was used to determine the frequency of each of the four nucleotides present in mapped reads at every genomic position with read coverage. We limited our analysis to nucleotide positions with a minimum combined read depth of 500 unique reads across the 20 biological replicates to maximize sensitivity of detecting modified nucleotides. Total RNA from HEK 293T cells (N = 2 biological replicates) or whole mouse brain (N = 6 biological replicates) was extracted using TRIzol (ThermoFisher) and treated with RNase-free DNase I (Promega). Poly(A) RNA was isolated using one round of selection with oligo(dT) 25 magnetic beads (New England Biolabs). This resulted in approximately 10 μg of poly(A) RNA for each replicate used in this study. Poly(A) RNA was subjected to fragmentation using RNA Fragmentation Reagents (ThermoFisher) for exactly 12 min at 75°C. This fragmentation protocol is identical to the m 1 A-seq protocol previously used to map m 1 A, and has been reported not to facilitate substantial m 1 A to m 6 A rearrangement 3 . Fragmented RNA was then incubated with 10 to 15 μg of m 1 A antibody per replicate and the antibody-RNA complexes were processed for crosslinking, immunoprecipitation, RNA 3' linker ligation, purification, and reverse transcription exactly as previously described 19, 36 . Following reverse transcription of purified peptide-RNA complexes, first-strand cDNA was circularized using CircLigase II ssDNA Ligase (EpiBio) to preserve the 3' end of the cDNA, and thus, sites of m 1 A-induced terminations of reverse transcription. To generate priming sites for library amplification, the cDNA was cut in the middle of the cDNA primer sequence using a single-stranded DNA oligo complementary to this sequence and FastDigest BamHI (ThermoFisher) as previously described 19, 36 . This generated priming sites for the Illumina P5 and P3 primers on either side of the first-strand cDNA, eliminating the need for a second-strand synthesis step. For library amplification, Accuprime Supermix I (ThermoFisher) and Illumina P5 and P3 primers were used (see Extended Data Table 7 ). PCR amplification cycle number was selected as previously described 36 . Amplified libraries were purified using AMPure XP magnetic beads (Beckman Coulter). Libraries were subjected to next-generation sequencing at the Epigenomics Core of Weill Cornell Medicine. Libraries were sequenced on an Illumina HiSeq 2500 and MiSeq instrument in single-end mode to generate 50-base reads.
RNA-seq
HEK 293T cell total RNA was extracted with TRIzol (ThermoFisher), treated with RNase-free DNase I (Promega), and poly(A) RNA was isolated using one round of selection with oligo(dT) 25 magnetic beads (New England Biolabs). RNA was then subjected to fragmentation using RNA Fragmentation Reagents (ThermoFisher) for exactly 12 min at 75°C. Fragmented RNA was then subjected to RNA 3' linker ligation using T4 RNA Ligase I (New England Biolabs) and reverse transcription using a primer complementary to the linker sequence and SuperScript III (ThermoFisher) (see Extended Data Table 7 ). First-strand cDNA was gel-purified using denaturing PAGE, and then circularized using Circligase II ssDNA Ligase (EpiBio). Circularized cDNA was then cut and amplified exactly as described above for m 1 A miCLIP. Resulting RNAseq libraries were subjected to next-generation sequencing at the Epigenomics Core of Weill Cornell Medicine. Libraries were sequenced on an Illumina HiSeq 2500 instrument in single-end mode to generate 50-base reads.
Read processing and alignment
After sequencing, reads from m 1 A miCLIP or RNA-seq libraries were trimmed of the 3' linker sequence and barcoded reverse transcription primer sequences using Flexbar (version 2.5) (see Extended Data Table 7 ). To demultiplex reads belonging to individual biological replicates, the pyBarcodeFilter.py script of the pyCRAC suite (version 1.2.2) was used. The random portion of the reverse transcription barcode was then moved into the sequence header using a custom awk script (available upon request). PCR duplicates were collapsed using pyFastqDuplicateRemover.py of the pyCRAC suite. Finally, reads were aligned to hg19 for HEK 293T cells or mm10 for mouse brain using Bowtie (version 1.
1.2).
Generation of m 1 A miCLIP clusters m 1 A miCLIP clusters of unique reads were generated using the CIMS software package for analysis of HITS-CLIP data 37,38 . To generate clusters and determine the cluster score (maximum of stacked reads), the tag2profile.pl, tag2cluster.pl, and extractPeak.pl scripts of the CIMS software package were used. A custom awk script was then used to filter for clusters of a minimum score (at least 20 stacked reads; script is available upon request).
Motif analyses
To search for a possible common sequence motif present in our HEK 293T cell m 1 A miCLIP dataset, we focused on potential motifs present in m 1 A miCLIP clusters in the 5' UTR, the region of predominant m 1 A miCLIP cluster enrichment. The genomic sequences of these clusters were retrieved using bedtools and subjected to motif discovery using the MEME suite (version 4.11.
4).

Metagene distribution analyses
To analyze the metagene distribution of m 1 A miCLIP clusters on mRNAs, MetaPlotR was used 39 , with in-house modifications. The density of m 1 A miCLIP coverage was normalized to that of RNAseq coverage to reveal any enrichments using a custom R script (available upon request). For the HEK 293T cell metagene, the in-house HEK 293T cell RNA-seq dataset described above was used for normalization. For the mouse brain metagene, a published whole-brain RNA-seq dataset was used 40 (accession code: GSE52564). To plot the coverage of transcription start sites by m 1 A miCLIP at higher resolution, the plotProfile tool of the Deeptools suite was used.
Examination of antibody crosslink sites around the transcription start site
For analysis of antibody crosslinks at the transcription start sites of mRNAs, we analyzed terminations of reverse transcription (i.e. 5' ends of reads) around these sites. To do so, the number of terminations was measured around RefSeq-annotated transcription start sites that had coverage in both m 1 A miCLIP and RNA-seq. Terminations were counted at positions ranging from the transcription start site to position +4 relative to the transcription start site. Then, transcription start sites were filtered for those that contained a minimum coverage of 5 unique reads at the transcription start site position in both m 1 A miCLIP and RNA-seq. This filtered set of transcription start sites was then used to compare the distributions of read terminations in m 1 A miCLIP and RNA-seq. We focused on terminations rather than misincorporations in m 1 A miCLIP is because the misincorporation profile of m 1 A is sequence-dependent, with both upstream and downstream nucleotides contributing to misincorporation variability 8 . Thus, we used the presence of terminations as a signature of antibody crosslinking events in our dataset. Additionally, while rare types of reverse transcriptases that read through m 1 A have been described 41 , standard reverse transcriptases, like the SuperScript III used in m 1 A miCLIP, produce frequent terminations at m 1 A residues 8, 42 .
Measurement of transcription start sites enriched by m 1 A miCLIP
To determine the types of transcription start sites overlapping m 1 A miCLIP clusters, we used a collection of transcription start sites that included RefSeq transcription start sites as well as recently-mapped transcription start site regions containing the m 6 Am mRNA extended cap 23 . The frequencies of all transcription start site types or those overlapping m 1 A miCLIP clusters were thus determined using this collective set.
Synthetic oligonucleotides used in this study
For biochemical analysis of various modifications present within the extended caps of mRNAs, synthetic oligonucleotides were generated as standards for mass spectrometry and/or thin-layer chromatography (see below; see Extended Data Table 7 
Liquid chromatography and mass spectrometry (LC-MS)
Poly(A) RNA was prepared for mass spectrometry as follows. Total RNA from HEK 293T cells was treated with TURBO DNase (ThermoFisher) according to the manufacturer's instructions, followed by two rounds of poly(A) selection using oligo(dT) magnetic beads (NEB). Small RNAs shorter than 200 nt were then removed from the poly(A) RNA using the RNeasy kit (Qiagen). This size selection was performed to prevent detection of extended cap structures that are known to be present in certain small RNAs, like small nuclear RNAs (snRNAs). Approximately 5 μg of DNase-treated, poly(A)-selected, and size-selected RNA was thus generated for each sample for mass spectrometry analysis. To release extended cap structures from the nucleotides comprising the internal portion of the RNA, RNA was digested with 2-4 units of Nuclease P1 (Sigma Aldrich) in a final buffer concentration of 30 mM sodium acetate (pH 5.5) for 3 hours at 37°C. Following digestion, the nuclease was removed from the samples using molecular weight cutoff centrifugal filters (VWR). The digested and purified RNA was finally dried using an Eppendorf Vacufuge and reconstituted with 70% acetonitrile (LC-MS grade; Sigma Aldrich) to a final concentration of 0.5 µg/µl. 2 µl of the resulting solution were subjected to MS analysis.
Samples were injected into an LC-MS/MS system comprised of an Agilent 1260 HPLC and an Agilent 6460 triple quadrupole mass spectrometer equipped with a JetStream electrospray ionization source. Positive ion monitoring and multiple reaction monitoring was used for detection of extended caps. The caps were resolved on an aqueous normal phase column (ANP, Cogent Diamond Hydride, 4 µm particle size, 150 mm x 2.1 mm; Microsolv). To achieve chromatographic separation of the cap structures from mononucleotides, the following gradient was used. The aqueous mobile phase (Buffer A) was 50% isopropanol with 0.025% acetic acid, and the organic mobile phase (Buffer B) was 90% acetonitrile containing 5 mM ammonium acetate. EDTA was added to the mobile phase in a final concentration of 6 µM. The final gradient applied was: 0-1.0 min 99% B, 1.0-7.0 min to 80% B, 7.0-18.0 min to 50% B, 18.0-19.0 min to 0% B and 19.1 to 29.0 min 99% B. The flow rate was 0.4 mL/min during data acquisition and 0.6 mL/min during column re-equilibration. Data was saved in centroid mode using MassHunter workstation acquisition software (Agilent). Data files were processed with MassHunter Qualitative Analysis Software (Agilent).
Exact operating source parameters for the LC-MS analysis are available upon request.
Biochemical examination of modifications at transcription start sites
To identify the initiating nucleotide structure in mRNAs bound by the m 1 A antibody, we utilized two dimensional thin layer chromatography (2D-TLC) analysis of mRNA extended caps as previously described 23 . For analysis of cellular RNA, we used HEK 293T cell poly(A) RNA or poly(A) RNA enriched using the m 1 A antibody as previously described 3, 4 . Oligonucleotide standards, input (antibody-unbound) poly(A) RNA, and m 1 A antibody-enriched poly(A) RNA were then subjected to 2D-TLC as previously described 23 , with one modification. To enhance resolution of m 1 A and m 1 A m from other nucleotide species, the second dimension of 2D-TLC resolution was performed using the following buffer: 60% ammonium sulfate in 100 mM sodium phosphate buffer of pH 6.8 (w/v), and a final concentration of 2% n-propanol.
Synthesis of N 1,6 -methyladenosine
To synthesize N 1,6 -methyladenosine, N 6 -methyladenosine (Selleckchem) was dissolved in dry DMF and followed with addition of iodomethane (Acros Organics; 10:1 molar ratio iodomethane:N 6 -methyladenosine). The mixture was stirred overnight at room temperature. The product was purified by flash chromatography on silica gel (EMD), eluting with methanol and dichloromethane (1:10 to 1:5; ACS or HPLC grade solvents). This resulted in a product yield of 46.3% N 1,6 -methyladenosine. Product identity was confirmed by nuclear magnetic resonance (NMR) and high resolution mass spectrometry (HR-MS).
NMR spectra were recorded using a 500-MHz Bruker DMX-500 instrument at room temperature, and chemical shifts were referenced to the residual solvent peak. 
Characterization of antibody affinity for various substrates
The specificity or affinity of the m 1 A antibody for various nucleosides, nucleotides, or cap structures was determined as follows. To determine the specificity of the m 1 A antibody for various nucleosides, two approaches were performed. For testing the specificity of the antibody for various nucleosides in the context of m 1 A miCLIP, the antibody was crosslinked to total cellular RNA in the presence of various competitor nucleotides. Antibody binding, crosslinking, and detection of crosslinked antibody-RNA complexes was performed exactly as in miCLIP, except with the inclusion of the competitor nucleotide during the antibody binding reaction.
For testing the specificity of the antibody for modified adenines, especially those resembling N 1 -methylated adenine, a previously described dot blot assay was performed wherein the competing molecule is added during antibody binding 1 . Competition assays are usually used to measure binding, rather than spotting the nucleotides to the membrane, since the manner of interaction of each nucleotide to the membrane is not known and can affect antibody binding. For measuring the affinity, the IC 50 of the various nucleotides and cap dinucleotides was measured. In these experiments, a series of the dot blot assays were performed, where serial dilutions of each competitor molecule (ranging from 10 µM to 1 nM) were used in parallel during antibody binding reactions. The dot blots were performed as follows: 250 ng of m 1 A-containing synthetic oligonucleotide (see Extended Data Table 7 ) were spotted in triplicate on a BrightStar membrane (ThermoFisher), allowed to briefly air-dry, and auto-crosslinked twice in a Stratalinker 2400 (Stratagene). Each membrane was rinsed briefly in PBST, then blocked for 1 h at room temperature in 5% milk in PBST. Each membrane was then placed into a pouch containing a 1:1000 dilution of the m 1 A antibody in 0.5% milk in PBST, and an appropriate concentration of competitor molecule. The antibody binding proceeded for 2 h at room temperature. Then, each membrane was washed three times in PBST (5 min per wash), and then incubated in a dilution of 1:2500 of secondary antibody (anti-mouse, GE # NA931 ; antirabbit, GE NA934) in 0.5% milk in PBST for 1 h at room temperature. Finally, the membrane was washed three times in PBST (5 min per wash), and developed using ECL Prime (GE). Membranes corresponding to a dilution series of a specific competitor molecule were imaged together using a ChemiDoc Imager (Bio-Rad). An ultra-deep RNA-seq dataset was derived from 20 independent biological replicates. Conceivably, some of the RNA fragments (black lines) contain "hard stop modifications" (red circles), and RNA fragments were reverse transcribed (cDNA, blue lines). For RNA fragments containing these modifications, the reverse transcriptase could terminate at the modification, produce a nucleotide misincorporation, or read through the modification. When the cDNA library is PCR-amplified and sequenced, nucleotide differences are detected between the aligned reads and genomic sequence matching the RNA-seq dataset. Misincorporations (open red circles) identified using this approach are indicative of putative modification sites. Examination of these misincorporations across multiple replicates is critical to distinguish modification sites and sequencing error, which occurs more dispersedly (blue circles). UTRs were annotated with their genomic sequence environment, and the sequences were analyzed for recurrent motifs. This resulted in significant enrichment of a pyrimidine-rich sequence motif that facilitates transcription initiation of mRNAs at adenosine (E = 3.3 x 10 -5 ).
Genomic and transcribed regions of the sequence motif are marked. conversion was seen. HPLC assay conditions were as previously described 23 .
Extended Data Figure 3 . Misincorporation mapping in mRNA a, Selection of read depth criteria for misincorporation mapping. To detect modification-induced misincorporations throughout the transcriptome, we first examined the coverage depth of the ultra-deep RNA-seq dataset at all genomic positions. At positions that had coverage, many positions were covered by 50 to 500 unique reads. However, for our analysis, we chose to analyze the subset of nucleotides that were covered by 500 or more unique reads in order to maximize the sensitivity of detecting hard stop modifications in mRNA. Here, in total, approximately 8 million positions of each type of nucleotide were covered by 500 or more reads. Thus, many nucleotides throughout the transcriptome were able to be evaluated for hard stop modifications. 
